A study on the global burden of non-melanoma skin cancer from 1990 to 2019

Abstract

IntroductionThis study aims to provide an overview and analysis of the global disease burden of non-melanoma skin cancer using data from the GBD 2019 database.Material and methodsThis study utilized the global GBD 2019 disease data. The data was categorized into various subgroups based on region, socio-demographic index (SDI), country, gender, and age. We analyzed Incidence Cases, Incidence Rate, disability-adjusted life years (DALYs), DALY Rate, as well as age-standardized indicators and their annualized percent change (EAPC).ResultsThe global burden of non-melanoma skin cancer exhibited an increasing trend from 1990 to 2019. The EAPC for age-standardized incidence rate (ASIR) was 1.13, and the EAPC for age-standardized DALY rate was 0.20. Geographic variations were observed, with the most substantial increase in ASIR observed in High-income North America (EAPC: 2.20), and a significant increase in age-standardized DALY rate in Central Asia (EAPC: 2.32). Countries with high SDI had the highest ASIR and showed the most significant increasing trend (EAPC: 1.97). Overall, the burden of disease for non-melanoma skin cancer increased in all countries globally from 1990 to 2019. The EAPC for incidence cases, DALYs, and ASIR was greater than 0 in almost all countries worldwide, indicating an overall increasing trend.ConclusionsThe global disease burden of non-melanoma skin cancer exhibited significant increasing changes from 1990 to 2019. Several countries in Asia, Africa, and North America experienced a severe disease burden.